Transoral Electromyographic Recordings in Botulinum Toxin

Abstract

Objective assessment of muscle function following botulinum toxin injections in laryngeal muscles is difficult in human subjects. We developed a rat laryngeal model for the study of botulinum toxin injection. A new laryngoscopic technique has made it possible to observe the rat larynx endoscopically and to obtain electromyographic measurements during and after injection of toxin. The electromyographic interference pattern, fibrillation potentials, and vocal fold movement were used for analyzing dose and volume effects of injected toxin. We conclude that the lowest dosage able to produce the maximal duration of functional laryngeal impairment is 0.07 U in a volume of 0.4 μL. This model will enable us to obtain physiologic and histologic parameters that can be used to assess the selection of optimal treatment regimens with botulinum toxin for the treatment of patients with spasmodic dysphonia.

Keywords

anterior tibialis muscle botulinum toxin compound muscle action potential electromyography larynx rat thyroarytenoid muscle

Get full access to this article

View all access options for this article.

References

Brown

Holland

Hopkins

Keynes

. An assessment of the signal for terminal sprouting within and between muscles. Brain Res 1980; 210: 145–51.

Shaari

Sanders

. Assessment of the biological activity of botulinum toxin. Therapy with botulinum toxin. New York, NY: Marcel Dekker, 1994: 159–70.

Duchen

. Changes in motor innervation and cholinesterase localization induced by botulinum toxin in skeletal muscle of the mouse: Difference between fast and slow muscles. J Neurol Neurosurg Psychiatry 1970; 33: 40–54.

Cichon

McCaffrey

Litchy

Knops

. The effect of botulinum toxin type A injection on compound muscle potential in an in vivo rat model. Laryngoscope 1995; 105: 144–8.

Cohen

Thompson

. Use of botulinum toxin to lateralize true vocal cords: A biochemical method to relieve bilateral abductor vocal cord paralysis. Ann Otol Rhinol Laryngol 1987; 96: 534–41.

George

Zimbler

B-L

Biller

Sanders

. Quantitative mapping of the effect of botulinum toxin injections in the thyroarytenoid muscle. Ann Otol Rhinol Laryngol 1992; 101: 888–92.

SAS Institute Inc. SAS/STAT user's guide, version 6. 4th ed. Vol 2. Cary, NC, 1989.

Cohen

. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960; 20: 37–46.

Inagi

Ford

Bless

Heisey

. Analysis of factors affecting botulinum toxin results in spasmodic dysphonia. J Voice 1997; 10: 306–13.

10.

Kobler

Datta

Goyal

Benecchi

. Innervation of the larynx, pharynx, and upper esophageal sphincter of the rat. J Comp Neurol 1994; 349: 129–47.

11.

Inagi

Schultz

Ford

. An anatomical study of the rat larynx: Establishing the rat model for neuromuscular research. Otolaryngol Head Neck Surg (in press).

12.

Rosen

Malmgren

Gacek

. Three-dimensional computer reconstruction of the distribution of neuromuscular junctions in the thyroarytenoid muscle. Ann Otol Rhinol Laryngol 1983; 92: 424–9.

13.

Claassen

Werner

. Fiber differentiation of the human laryngeal muscles using the inhibition reactivation myofibrillar ATPase technique. Anat Embryol (Berl) 1992; 186: 341–6.

14.

Valls-Sole

Tolosa

Ribera

. Neurophysiological observation on the effects of botulinum toxin treatment in patients with dystonic blepharospasm. J Neurol Neurosurg Psychiatry 1991; 54: 310–3.

15.

. Botulism: Electrophysiological studies. Ann Neurol 1977; 1: 481–5.

Transoral Electromyographic Recordings in Botulinum Toxin—Injected Rat Larynges

Abstract

Keywords

Get full access to this article

References